11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma

Diagnostic Molecular Pathology

Volumn 21, Issue 3, 2012, Pages 134-137

  Clauditz, Till Sebastian ^a   Gontarewicz, Artur ^a   Wang, Chia Jung ^a   Münscher, Adrian ^a   Laban, Simon ^a   Tsourlakis, Maria Christina ^a   Knecht, Rainald ^a   Sauter, Guido ^a   Wilczak, Waldemar ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

MAML2; MEC1; MECT1 MALM2 fusion; mucoepidermoid carcinoma; salivary gland tumors

Indexed keywords

ACINAR CELL CARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; CHROMOSOME 11Q; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 19; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE FUSION; GENE LOCUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAML2 GENE; MECT1 GENE; MUTATION; PRIORITY JOURNAL; SALIVARY GLAND CARCINOMA; TISSUE MICROARRAY; WARTHIN TUMOR;

ADENOMA; CARCINOMA, MUCOEPIDERMOID; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 19; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROARRAY ANALYSIS; ONCOGENE PROTEINS, FUSION; SALIVARY GLAND NEOPLASMS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84865770943     PISSN: 10529551     EISSN: 15334066     Source Type: Journal    
DOI: 10.1097/PDM.0b013e318255552c     Document Type: Article

References (33)

1. Marchevsky A. Bronchial gland tumors. In: Saldana MJ, ed. Pathologyof Pulmonary Disease. Philadelphia: Lippincott; 1994:597-607.
2. Goode R, Auclair P, Ellis G. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer. 1998;82:1217-1224. (Pubitemid 28155381)
3. Seethala R. An update on grading of salivary gland carcinomas. Head Neck Pathol. 2009;3:69-77.
4. Seethala R, Hoschar A, Bennett A, et al. Reproducibility of grading in salivary gland mucoepidermoid carcinoma and correlation with outcome: does system really matter? Mod Pathol. 2008;21:241A.
5. Brandwein M, Ivanoov K, Wallace D, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histologic grading. Am J Surg Pathol. 2001;25:835-845. (Pubitemid 32594976)
6. Luna M. Salivary mucoepidermoid carcinoma: revisited. Adv Anat Pathol. 2006;13:293-307. (Pubitemid 44673445)
7. Tonon G, Modi S, Wu L, et al. T(11,19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signalling pathway. Nat Genet. 2003;33:208-213. (Pubitemid 36177076)
8. Enlund F, Behboudi A, Andren Y, et al. Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors. Exp Cell Res. 2004;292:21-28. (Pubitemid 38058260)
9. Coxon A, Rozenblum E, Park Y, et al. Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic ANP/CREB regulated genes. Cancer Res. 2005;65:7137-7144. (Pubitemid 41161243)
10. Wu L, Liu J, Gao P, et al. Transforming activity of MECT1- MAML2 fusion oncoprotein is mediated by constitutive CREB activation. EMBO J. 2005;24:2391-2402. (Pubitemid 41032590)
11. Behboudi A, Enlund F, Winnes M, et al. Molecular classification of mucoepidermoid carcinomas - prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer. 2006;45:470-481.
12. Okabe M, Miyabe S, Nagatsuka H, et al. MECT1-MAML2 fusion transcript defines a favourable subset of micoepidermoid carcinoma. Clin Cancer Res. 2006;12:3902-3907. (Pubitemid 44078073)
13. Stenman G. Fusion oncogenes and tumor type specificity - insights from salivary gland tumors. Semin Cancer Biol. 2005;15:224-235.
14. Martins C, Cavaco B, Tonon G, et al. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands. J Mol Diagn. 2004;6:205-210. (Pubitemid 39136647)
15. Tirado Y, Williams M, Hanna E, et al. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin''s tumors: implications for histogenesis and biologic behaviour. Genes Chromosomes Cancer. 2007;46:708-715. (Pubitemid 46802338)
16. Johansson M, Mandahl N, Johansson L, et al. Translocation 11;19 in a mucoepidermoid tumor of the lung. Cancer Genet Cytogenet. 1995;80:85-86.
17. Roberts T Jr, Barry M, Skarin A. Mucoepidermoid carcinoma of the lung with t(11:19)(q21:p13): a link to new biology. Clin Adv Hematol Oncol. 2003;1:486-487.
18. Serra A, Schackert H, Mohr B, et al. t(11;19)(q21;p12Bp1311) and MECT1-MAML2 fusion transcript expression as a prognostic marker in infantile lung mucoepidermoid carcinoma. J Pediatr Surg. 2007;42:E23-E29. (Pubitemid 47017323)
19. Röser K, Fehr A, Belge G, et al. Subtyping of carcinoma expleomorphic adenoma by t(11;19) translocation assay [abstract]. Oral Oncol Suppl. 2007;2:223.
20. Bullerdiek J, Haubrich J, Meyer K, et al. Translocation t(11;19)(q21;p13 1) as the sole chromosome abnormality in a cystadenolymphoma (Warthin's tumor) of the parotid gland. Cancer Genet Cytogenet. 1988;35:129-132. (Pubitemid 18266311)
21. Winnes M, Enlund F, Mark J, et al. The MECT1-MAML2 gene fusion and benign Warthin's tumor: is the MECT1-MAML2 gene fusion specific to mucoepidermoid carcinoma? J Mol Diagn. 2006;8:394-395.
22. Kaye F. Emerging biology of malignant salivary gland tumors offer new insights into classification and treatment of mucoepidermoid carcinoma. Clin Cancer Res. 2006;12:3878-3881. (Pubitemid 44078069)
23. Fehr A, Röser K, Belge G, et al. A closer look at Warthins's tumors and the t(11;19). Cancer Genet Cytogenet. 2008;180:135-139.
24. Bell D, Luna M, Weber R, et al. CRTC1/MAML2 fusion transcript in Warthin's tumor and mucoepidermoid carcinoma: evidence for a common generic association. Genes Chromosomes Cancer. 2008;47:309-314. (Pubitemid 351323760)
25. Obaidat N, Alsaad K, Ghazarian D. Skin adnexal neoplasms-part 2: an approach to tumours of cutaneous sweat glands. J Clin Pathol. 2007;60:145-159.
26. Winnes M, Molne L, Suurkula M, et al. Frequent fusion of the CRCT1 and MAML2 genes in clear cell variants of cutaneous hidradenomas. Genes Chromosomes Cancer. 2007;46:559-563. (Pubitemid 46649570)
27. Kazakov D, Vanecek T, Belousova I, et al. Skin-type hidradenoma of the breast parenchyma with t(11;19) translocation: hidradenoma of the breast. Am J Dermatopathol. 2007;29:457-461. (Pubitemid 47463855)
28. Kononen J, Bubendorf L, et al. Tissue microarrays for highthroughput molecular profiling of tumor specimens. Nat Med. 1998;4:844-847. (Pubitemid 28331029)
29. Bubendorf L, Kononen J, et al. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res. 1999;59:803-806. (Pubitemid 29086730)
30. Seethala R, Dacic S, Cieply K, et al. A Reappraisal of the MECT1/ MAML2 translocation in salivary mucoepidermoid carcinomas. Am J Surg Pathol. 2010;34:1106-1121.
31. Behboudi A, Winnes M, Gorunova L, et al. Clear cell hidradenoma of the skin: a third tumor type with a t(11;19)-associated TORC1-MAML2 gene fusion. Genes Chromosome Cancer. 2005;43:202-205. (Pubitemid 40570740)
32. Riedlinger W, Hurley M, Dehner L, et al. Mucoepidermoid carcinoma of the skin: a distinct entity from adenosquamos carcinoma: a case study with a review of the literature. Am J Surg Pathol. 2005;29:131-135. (Pubitemid 40023962)
33. Fitzgibbon J, Googe P. Mucinous differentiation in adnexal sweat gland tumors. J Cutan Pathol. 1996;23:259-263. (Pubitemid 26181315)